Literature DB >> 19417088

Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor.

Peter Klover1, Weiping Chen, Bing-Mei Zhu, Lothar Hennighausen.   

Abstract

In skeletal muscle, STAT5a/b transcription factors are critical for normal postnatal growth, whole-animal glucose homeostasis, and local IGF-1 production. These observations have led us to hypothesize that STAT5a/b are critical for maintenance of normal muscle mass and function. To investigate this, mice with a skeletal muscle-specific deletion of the Stat5a/b genes (Stat5MKO) were used. Stat5MKO mice displayed reduced muscle mass, altered fiber-type distribution and reduced activity. On a molecular level, gene expression in skeletal muscle of Stat5MKO and control mice was analyzed by microarrays and real-time PCR, both in the presence and absence of growth hormone (GH) stimulation. Expression of several genes involved in muscle growth and fiber type were significantly changed. Specifically, in the quadriceps, a muscle almost exclusively composed of type II fibers, the absence of STAT5a/b led to increased expression of several genes associated with type I fibers and the de novo appearance of type I fibers. In addition, it is shown here that expression of the androgen receptor gene (Ar) is controlled by GH through STAT5a/b. The link between STAT5a/b and Ar gene is likely through direct transcriptional regulation, as chromatin immunoprecipitaion of the Ar promoter region in C2C12 myoblasts was accomplished by antibodies against STAT5a. These experiments demonstrate an important role for STAT5a/b in skeletal muscle physiology, and they provide a direct link to androgen signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417088      PMCID: PMC2735360          DOI: 10.1096/fj.08-128215

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle.

Authors:  Ana M Fernández; Joëlle Dupont; Roger P Farrar; Sukho Lee; Bethel Stannard; Derek Le Roith
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.

Authors:  C J Auernhammer; C Bousquet; S Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.

Authors:  Galina Götherström; Bengt-Ake Bengtsson; Katharina Stibrant Sunnerhagen; Gudmundur Johannsson; Johan Svensson
Journal:  Clin Endocrinol (Oxf)       Date:  2005-01       Impact factor: 3.478

4.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  Testosterone action on skeletal muscle.

Authors:  Karen L Herbst; Shalender Bhasin
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-05       Impact factor: 4.294

6.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.

Authors:  Yasutomi Kamei; Shinji Miura; Miki Suzuki; Yuko Kai; Junko Mizukami; Tomoyasu Taniguchi; Keiji Mochida; Tomoko Hata; Junichiro Matsuda; Hiroyuki Aburatani; Ichizo Nishino; Osamu Ezaki
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

8.  Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.

Authors:  J P Drenth; S H Van Uum; M Van Deuren; G J Pesman; J Van der Ven-Jongekrijg; J W Van der Meer
Journal:  J Appl Physiol (1985)       Date:  1995-11

9.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

Authors:  Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

Review 10.  Skeletal muscle fiber type: influence on contractile and metabolic properties.

Authors:  Juleen R Zierath; John A Hawley
Journal:  PLoS Biol       Date:  2004-10-12       Impact factor: 8.029

View more
  29 in total

1.  Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice.

Authors:  Mahendra D Mavalli; Douglas J DiGirolamo; Yong Fan; Ryan C Riddle; Kenneth S Campbell; Thomas van Groen; Stuart J Frank; Mark A Sperling; Karyn A Esser; Marcas M Bamman; Thomas L Clemens
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Fine-mapping of genes determining extrafusal fiber properties in murine soleus muscle.

Authors:  A M Carroll; R Cheng; E S R Collie-Duguid; C Meharg; M E Scholz; S Fiering; J L Fields; A A Palmer; A Lionikas
Journal:  Physiol Genomics       Date:  2017-01-13       Impact factor: 3.107

3.  BDNF is a mediator of glycolytic fiber-type specification in mouse skeletal muscle.

Authors:  Julien Delezie; Martin Weihrauch; Geraldine Maier; Rocío Tejero; Daniel J Ham; Jonathan F Gill; Bettina Karrer-Cardel; Markus A Rüegg; Lucía Tabares; Christoph Handschin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-18       Impact factor: 11.205

Review 4.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

Review 5.  Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism.

Authors:  Myunggi Baik; Ji Hoon Yu; Lothar Hennighausen
Journal:  Ann N Y Acad Sci       Date:  2011-07       Impact factor: 5.691

6.  Skeletal muscle mitochondrial function and exercise capacity are not impaired in mice with knockout of STAT3.

Authors:  Jessica R Dent; Byron Hetrick; Shahriar Tahvilian; Abha Sathe; Keenan Greyslak; Samuel A LaBarge; Kristoffer Svensson; Carrie E McCurdy; Simon Schenk
Journal:  J Appl Physiol (1985)       Date:  2019-09-12

7.  Feedlot performance and biological responses to coated and non-coated steroidal implants containing trenbolone acetate and estradiol benzoate in finishing beef steers1,2,3.

Authors:  Zachary K Smith; Jongkyoo Kim; Bradley J Johnson
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

8.  Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.

Authors:  Archana Vijayakumar; Nicholas J Buffin; Emily J Gallagher; Jeffrey Blank; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

9.  Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle.

Authors:  David W Frederick; Emanuele Loro; Ling Liu; Antonio Davila; Karthikeyani Chellappa; Ian M Silverman; William J Quinn; Sager J Gosai; Elisia D Tichy; James G Davis; Foteini Mourkioti; Brian D Gregory; Ryan W Dellinger; Philip Redpath; Marie E Migaud; Eiko Nakamaru-Ogiso; Joshua D Rabinowitz; Tejvir S Khurana; Joseph A Baur
Journal:  Cell Metab       Date:  2016-08-09       Impact factor: 27.287

10.  Muscle ciliary neurotrophic factor receptor α promotes axonal regeneration and functional recovery following peripheral nerve lesion.

Authors:  Nancy Lee; Rachel P Spearry; Kendra M Leahy; Rachel Robitz; Dennis S Trinh; Carter O Mason; Rebekah J Zurbrugg; Myra K Batt; Richard J Paul; A John Maclennan
Journal:  J Comp Neurol       Date:  2013-09-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.